SynthesisParasitology research2019
Human Babesiosis in China: a systematic review.
Synthesis in Parasitology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 47 citations in OpenAlex.
- Molecular epidemiology ofFrontiers in microbiology · 2026Article
- Theileria luwenshuni and Novel Babesia spp. Infections in Humans, Yunnan Province, China.Emerging infectious diseases · 2025Article
- Infections by Ehrlichia spp., Anaplasma spp. and Babesia spp. In Puerto Ordaz, Bolívar, VenezuelaBiomedica : revista del Instituto Nacional de Salud · 2025Article
- Tick-Borne Infectious Diseases in China, 2003-2023.China CDC weekly · 2025Review
- Prevalence and genetic diversity of Babesia microti in rodents from central and southern Shanxi, China.Parasites & vectors · 2025Article
- Diversity of piroplasmids in wild animals in Brazil: a review.Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2025Review
- Research progress on diagnostic techniques for differentFrontiers in cellular and infection microbiology · 2025Review
- Persistent human babesiosis with low-grade parasitemia, challenges for clinical diagnosis and management.Heliyon · 2024Review
- Case Report: Diagnosis of Hemolytic Anemia from Babesia and Secondary Multi-Pathogen Pneumonia Using a Metagenomic Next-Generation Sequencing Approach.Infection and drug resistance · 2024Article
- Prevalence and molecular detection of Babesia microti in rodents in Southeastern Shanxi, China.PloS one · 2024Article
- A conserved protein of Babesia microti elicits partial protection against Babesia and Plasmodium infection.Parasites & vectors · 2023Article
- Nucleic Acid Prevalence of ZoonoticTropical medicine and infectious disease · 2023Review
- Imported human babesiosis in the Republic of Korea, 2019: two case reports.Parasites, hosts and diseases · 2023Article
- Identification of Bacterial Communities and Tick-Borne Pathogens inTropical medicine and infectious disease · 2022Article
- Nested qPCR assay to detect Babesia duncani infection in hamsters and humans.Parasitology research · 2022Article
- Cell-based carrier for targeted hitchhiking delivery.Drug delivery and translational research · 2022Review
- A Fluorescent Recombinase Aided Amplification Assay for Detection of Babesia microti.The Korean journal of parasitology · 2022Article
- Interactions between Babesia microti merozoites and rat kidney cells in a short-term in vitro culture and animal model.Scientific reports · 2021Article
- The Global Emergence of Human Babesiosis.Pathogens (Basel, Switzerland) · 2021Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human babesiosis, a worldwide emerging tick-borne disease, is caused by the intraerythrocytic apicomplexan parasite, babesia. In recent years, the number of infected patients globally has continued to rise, and thus human babesiosis poses a significant public health threat. Therefore, stronger initiatives should be undertaken to prevent further spread and development of this disease. In the present review, we summarize the epidemiology of reported human babesiosis cases in China from 1993 until now. The data show that Babesia microti is the dominant species causing human babesiosis in China and has led to more than 100 human infections thus far, where Babesia crassa-like is the second-most common. Moreover, Guangxi province is the second-most infected area after the Heilongjiang province. We also review the babesia life cycle, manifestation, diagnosis, and treatment. Additionally, we discuss babesiosis prevention strategies to raise public awareness, and also provide suggestions for improved babesiosis control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.